GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Haemonetics Corp (STU:HAZ) » Definitions » Cyclically Adjusted Book per Share

Haemonetics (STU:HAZ) Cyclically Adjusted Book per Share : €15.62 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Haemonetics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Haemonetics's adjusted book value per share for the three months ended in Mar. 2024 was €17.389. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €15.62 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Haemonetics's average Cyclically Adjusted Book Growth Rate was 2.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 3.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 2.90% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 3.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Haemonetics was 11.70% per year. The lowest was 1.60% per year. And the median was 7.30% per year.

As of today (2024-05-24), Haemonetics's current stock price is €80.50. Haemonetics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €15.62. Haemonetics's Cyclically Adjusted PB Ratio of today is 5.15.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Haemonetics was 9.02. The lowest was 1.94. And the median was 4.00.


Haemonetics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Haemonetics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haemonetics Cyclically Adjusted Book per Share Chart

Haemonetics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.98 13.26 14.24 14.97 15.62

Haemonetics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.97 15.56 16.41 15.57 15.62

Competitive Comparison of Haemonetics's Cyclically Adjusted Book per Share

For the Medical Instruments & Supplies subindustry, Haemonetics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haemonetics's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Haemonetics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Haemonetics's Cyclically Adjusted PB Ratio falls into.



Haemonetics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Haemonetics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=17.389/131.7762*131.7762
=17.389

Current CPI (Mar. 2024) = 131.7762.

Haemonetics Quarterly Data

Book Value per Share CPI Adj_Book
201406 11.664 100.560 15.285
201409 12.406 100.428 16.279
201412 13.134 99.070 17.470
201503 14.773 99.621 19.541
201506 13.861 100.684 18.141
201509 13.674 100.392 17.949
201512 13.003 99.792 17.171
201603 12.722 100.470 16.686
201606 12.473 101.688 16.164
201609 12.952 101.861 16.756
201612 14.101 101.863 18.242
201703 13.234 102.862 16.954
201706 13.095 103.349 16.697
201709 12.757 104.136 16.143
201712 13.023 104.011 16.499
201803 11.658 105.290 14.591
201806 11.173 106.317 13.849
201809 11.643 106.507 14.405
201812 11.086 105.998 13.782
201903 11.585 107.251 14.234
201906 10.301 108.070 12.561
201909 10.474 108.329 12.741
201912 10.262 108.420 12.473
202003 10.558 108.902 12.776
202006 10.665 108.767 12.921
202009 11.184 109.815 13.421
202012 11.633 109.897 13.949
202103 12.082 111.754 14.247
202106 11.016 114.631 12.664
202109 11.629 115.734 13.241
202112 12.654 117.630 14.176
202203 13.310 121.301 14.459
202206 14.203 125.017 14.971
202209 14.550 125.227 15.311
202212 14.521 125.222 15.281
202303 15.144 127.348 15.671
202306 15.739 128.729 16.112
202309 16.503 129.860 16.747
202312 17.033 129.419 17.343
202403 17.389 131.776 17.389

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Haemonetics  (STU:HAZ) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Haemonetics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=80.50/15.62
=5.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Haemonetics was 9.02. The lowest was 1.94. And the median was 4.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Haemonetics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Haemonetics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Haemonetics (STU:HAZ) Business Description

Traded in Other Exchanges
Address
125 Summer Street, Boston, MA, USA, 02110
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Haemonetics (STU:HAZ) Headlines

No Headlines